The deal priced below last closing price of $42.88. Goldman Sachs, Morgan Stanley, BofA and JPMorgan are acting as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDLN:
- Medline announces launch of secondary offering of Class A common stock
- Medline files to sell 75M shares of Class A common stock for holders
- Medline price target raised to $56 from $52 at Truist
- Conservative 2026 Guidance and Strong Segment Fundamentals Underpin Buy Rating and $53 Target for Medline
- Medline price target raised to $54 from $49 at Goldman Sachs